BIVI CIK: 1580149

BioVie Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
–
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−27.3
FY23:
−45.1
FY24:
−32.2
FY25:
−18.1
FY26:
−22.7
(positive)
Change from FY22 to FY26
millions USD
FY22:
−27.0
FY23:
−44.3
FY24:
−30.8
FY25:
−17.0
FY26:
−21.9
(positive)
Change from FY22 to FY26
millions USD
FY22:
−26.1
FY23:
−50.3
FY24:
−32.1
FY25:
−17.5
FY26:
−22.1
(positive)
Change from FY22 to FY26
millions USD
FY22:
−26.1
FY23:
−50.3
FY24:
−32.1
FY25:
−17.5
FY26:
−22.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data